Ryan Crowe | Vice President, Investor Relations |
Leonard Schleifer | President, Chief Executive Officer |
George Yancopoulos | President, Chief Scientific Officer |
Marion McCourt | Executive Vice President, Head of Commercial |
Robert Landry | Executive Vice President, Chief Financial Officer |
Evan Seigerman | BMO |
Tyler Van Buren | Cowen |
Salveen Richter | Goldman Sachs |
Matthew Harrison | Morgan Stanley |
Tim Anderson | Wolfe Research |
Mohit Bansal | Wells Fargo |
Christopher Raymond | Piper Sandler |
Colin Bristow | UBS |
Brian Abrahams | RBC |
Carter Gould | Barclays |
Hello, and welcome to Regeneron Pharmaceuticals' Third Quarter 2022 Earnings Conference Call. My name is Towanda, and I will be your operator for today’s call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] Please note that this conference is being recorded.